ACTIVE

Ceres Pharma

Financial year 2025 · closed on 31/12/2025
Net result
-14,4 M €
-37.1% YoY
Revenue
35,3 M €
+0.8% YoY
Equity
-1,6 M €
-112.1% YoY
Workforce
37,0 ETP
-12.1% YoY

What does Ceres Pharma do?

Ceres Pharma is a Public limited company incorporated in 2015. Its main activity is: Manufacture of other food products n.e.c.. Its registered office is in Gent. It employs on average 37,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0641.953.324
Incorporation
28/10/2015
Legal form
Public limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
Contributed capital
50 375 234,71 €
Latest accounts
31/12/2025
Average workforce
37,0 ETP
Joint committees (2)
  • 116
  • 207
Signals
Positive EBITDAHealthy social debtsHigh revenue
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2025202420232022202120202019201820172017
Income statement
Revenue35,3 M €35 M €42,4 M €34,6 M €33,1 M €30,4 M €26,8 M €
EBITDA2,8 M €4,1 M €3,4 M €452,8 k €3,8 M €4,7 M €2,4 M €-161,4 k €-571,7 k €-1 M €
Operating result-13,7 k €748,1 k €860,4 k €-1,8 M €645,7 k €1,7 M €-732,2 k €-1,8 M €-1,2 M €-2,3 M €
Net result-14,4 M €-10,5 M €-6,3 M €-4,6 M €-2,6 M €-1,1 M €-3,5 M €-3,7 M €-2 M €-3,3 M €
Balance sheet
Equity-1,6 M €12,8 M €18,7 M €11,4 M €7,8 M €-7,7 M €-6,6 M €-3,1 M €-2,3 M €-1,8 M €
Total assets265,9 M €214,7 M €173,9 M €124 M €87,7 M €55,1 M €53,6 M €46,3 M €19,1 M €9 M €
Cash395,8 k €3,6 M €18 M €6,6 M €7,3 M €1,9 M €2,6 M €493,8 k €2,2 M €399,2 k €
Debts263,3 M €198,8 M €153,1 M €111,5 M €79,1 M €61,7 M €59,2 M €48,2 M €21,1 M €10,4 M €
Other
Workforce37,0 ETP42,1 ETP45,6 ETP38,1 ETP43,5 ETP42,0 ETP41,8 ETP31,9 ETP11,3 ETP10,9 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 18 ended

Active mandates

Ceres Invest

Director · since 28 octobre 2021 · until 28 octobre 2027 · 0775.683.264

Represented by Mario Debel

Active

Ended mandates

Aquitania

Director · since 28 octobre 2021 · 0666.678.822

Represented by Anja Imschoot

Ended
Ceres Invest

bestuurder · since 28 octobre 2021 · until 28 octobre 2027 · 0775.683.264

Represented by Mario Debel

Ended
CRESCEMUS

Director · since 31 juillet 2020 · until 28 octobre 2021 · 0521.873.163

Represented by Pieter Bourgeois

Ended
CRESCEMUS

Director · since 31 juillet 2020 · until 04 juin 2027 · 0521.873.163

Represented by Pieter Bourgeois

Ended
At this address

Other companies at this address

CompanyCBE no.
2PHARMAActive
0886.662.746
2PHARMA HOLDINGActive
0644.751.377
0474.817.869
0893.541.630
Ceres InvestActive
0775.683.264
0407.326.754
CONESSENCEActive
0819.266.552
0794.812.555
0681.915.443
CREDOPHARActive
0849.730.193
DGPharmaActive
0508.925.544
DRIEPUNTNULActive
1021.711.292
HR ESSENTIALSActive
0721.702.467
KOUTERLOSActive
0450.036.349
LabopharActive
0643.723.177
MD PharmaActive
0667.779.672
PADEL FACTORYActive
0801.951.260
0865.651.952
0884.649.304
0421.364.139
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date06/07/202630/07/202525/07/202429/08/202311/08/202216/07/2021
General meeting30/06/202630/06/202530/06/202429/08/202315/07/202214/07/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

11 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202530/06/202606/07/2026DutchPDF
Full model31/12/202430/06/202530/07/2025DutchPDF
Full model31/12/202330/06/202425/07/2024DutchPDF
Full model31/12/202229/08/202329/08/2023DutchPDF
Consolidated accounts31/12/202213/09/202302/10/2023DutchPDF
Full model31/12/202115/07/202211/08/2022DutchPDF
Full model31/12/202014/07/202116/07/2021DutchPDF
Full model31/12/201921/08/202025/08/2020DutchPDF
Abridged model31/12/201822/08/201930/08/2019DutchPDF
Abridged model31/12/201722/08/201828/08/2018DutchPDF
Abridged model31/03/201701/09/201705/10/2017DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 18 ended

Active mandates

Ceres Invest

Director · since 28 octobre 2021 · until 28 octobre 2027 · 0775.683.264

Represented by Mario Debel

Active

Ended mandates

Aquitania

Director · since 28 octobre 2021 · 0666.678.822

Represented by Anja Imschoot

Ended
Ceres Invest

bestuurder · since 28 octobre 2021 · until 28 octobre 2027 · 0775.683.264

Represented by Mario Debel

Ended
CRESCEMUS

Director · since 31 juillet 2020 · until 28 octobre 2021 · 0521.873.163

Represented by Pieter Bourgeois

Ended
CRESCEMUS

Director · since 31 juillet 2020 · until 04 juin 2027 · 0521.873.163

Represented by Pieter Bourgeois

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares28/11/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Mandates19/08/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates03/09/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares27/05/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares31/01/2024
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares17/05/2023
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares18/10/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Registered office15/02/2022
    MAATSCHAPPELIJKE ZETEL
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-14,4 M €
  2. 2024
    Annual accounts 2024-10,5 M €
  3. 13/05/2024
    augmentation_capital
  4. 2023
    Annual accounts 2023-6,3 M €
  5. 21/12/2023
    augmentation_capital
  6. 01/07/2023
    nominationWouter Coppens — Commissaris
  7. 01/07/2023
    nominationWouter Coppens — commissaris
  8. 05/05/2023
    augmentation_capital
  9. 2022
    Annual accounts 2022-4,6 M €
  10. 2021
    Annual accounts 2021-2,6 M €
  11. 2020
    Annual accounts 2020-1,1 M €
  12. 2019
    Annual accounts 2019-3,5 M €
  13. 2018
    Annual accounts 2018-3,7 M €
  14. 2017
    Annual accounts 2017-2 M €
  15. 2017
    Annual accounts 2017-3,3 M €
  16. 28/10/2015
    IncorporationPublic limited company